"Regarding Neal Halsey http://www.vaccinesafety.com
There were two meetings on vaccines and diabetes. There was no consensus reached in either meeting however people are misrepresenting the truth by claiming there was a consensus. Neal Halsey appeared to admit under oath that the people at the Johns Hopkins meeting told him they refused to sign a consensus statement refuting my findings. Neal Halsey continues to claim a consensus however. It was brought up under oath that Neal Halsey's vaccine organization was receiving in excess of $100,000 from vaccine manufacturers and the conference was not an objective conference."--Bart Classen
"Dr. Samuel Katz of Duke University has served as chair of both the ACIP and the Red Book committees. He co-chairs a group called the Vaccine Initiative, which is an information and advocacy group that benefited from start-up funds from at least six vaccine manufacturers. He is listed as an advisory board member to the Immunization Action Coalition (which includes the Coalition for Hepatitis B), an advocacy group that receives funding from several vaccine makers, including SmithKline Beecham, Merck and Wyeth-Lederle........Dr. Neal Halsey of Johns Hopkins University http://www.vaccinesafety.
Like Katz, he is a vaccine pioneer and served on ACIP and the Red Book committees. He, too, is an advisor to the Immunization Action Coalition and the Hepatitis B Coalition. Halsey is also director of the Institute for Vaccine Safety, which he founded at Johns Hopkins to provide a forum on vaccine safety, among other things. According to a Johns Hopkins' spokesperson, the institute receives funds from Merck, SmithKline Beecham, North American Vaccines, Connaught/Pasteur Merrieux and Wyeth-Lederle."----Nicholas Regush ABCNEWS.com
4. Conflicts of interest of consultants:
At least three consultants participated in the discussion of the Rotashield vaccine on December 12, 1997. They were:
a.) Dr. Neal Halsey: Dr. Halsey has been one of the leading investigators and advocates in the area of vaccines. In addition to numerous grants and contracts from different vaccine manufacturers, Dr. Halsey has received frequent reimbursements for travel expenses and honoraria from companies such as Merck. Importantly, at the time of the Rotashield approval meeting, Dr. Halsey was seeking start-up funds from most of the vaccine manufacturers for the establishment of an institute for vaccine safety at Johns Hopkins University, where he works. He has already received $50,000 from Merck and was awaiting funds from Wyeth Lederle (Exhibit 56). Dr. Halsey also participated in the rotavirus working group of the ACIP.[xlii] Also, Dr. Halsey was the Chair of the Committee on Infectious Diseases and representative of the American Academy of Pediatrics which, in conjunction with the CDC, sets and advertises the recommendations for schedules and dosages of immunizations. He was granted a waiver for participation,[xliii] participated during the morning session and then recused himself at the beginning of the afternoon session due to conflicts that were not disclosed in the minutes for the meeting. Finally, Dr. Halsey’s employer, Johns Hopkins University, is also the employer of Dr. Clements-Mann, who was excluded from the discussions.
Conflicts of Interest in Vaccine Policy Making
Institute for Vaccine Safety
Core Personnel: Details/photos
Neal A. Halsey, MD, Director
Lawrence H. Moulton, PhD, Co-Director
Tina Proveaux, Coordinator
Saad B. Omer, MBBS, MPH, Associate Director for Data Management
Donations to the Institute for Vaccine Safety are always welcome. Please visit our Donations page.
The Institute for Vaccine Safety received start up financial support from vaccine manufacturers in 1997 and 1998. In 2001, IVS sponsored a workshop on bifurcated needles for smallpox administration with Becton Dickinson. IVS has not received support from manufacturers or any other corporate sponsor since then.
Current IVS activities are supported through general Johns Hopkins funds and donated time as a public service.